Liver Transplant Outcomes with ’Marginal’ and Benchmark Allografts Similar
Study findings encourage aggressive use of liver allografts Outcomes among liver transplant...
Read More
Transplantation
Conference Highlights: AATS 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Read MoreSex Inequities in Liver Transplant Result Longer Wait Times, Death for Women
Mitigating geographic disparities not enough Sex-based inequities in access to liver transplants won’t necessarily be solved by just enacting policies designed to mitigate geographic disparities in liver allocations.In...
Read MoreCovid-19: High Mortality Seen in Heart Transplant Patients
Small series points to complex issues for HT patients with Covid-19 Over an 8-week period beginning March 1, doctors at a large academic medical center in New York confirmed SARS-CoV-2 infection in 28 heart transplant patients,...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read More